u/ravi_bergstrom
Contributes reviews on supplier material. Based in Plovdiv.
member · joined 15 Jun 2025
Comments — page 2 of 5
comment on reading exit scam threads from 2024 and half of it aged badly in c/scamalerts · 1 points · 4 months ago
a dispute resolves, edit the post and say so
comment on my hs-CRP moved and I cannot work out whether network is why in c/cryptopay · 1 points · 4 months ago
network selection matters, wrong chain is the expensive typo
comment on three years of integration threads, summarised so you do not have to read them in c/hplc · 5 points · 4 months ago
instrument quality is less important than analyst consistency
comment on [Meta] proposal — a flair for plateau posts in c/semaglutide · 0 points · 4 months ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on someone explain exit scam to me like I have not read a paper in years in c/scamalerts · 2 points · 4 months ago
Strongly agree. The dispute resolved and the record stayed updated.
comment on tried province for 15 weeks. here is what happened. in c/glp1canada · 39 points · 5 months ago
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
comment on Ozempic is the most under-discussed thing in c/newbiequestions in c/semaglutide · 47 points · 5 months ago
Disagree. What you are describing is consistent with 2.4mg, not with what you concluded.
comment on week 51 check-in — 42kg down, constipation manageable, one thing confusing me in c/glp1canada · 25 points · 5 months ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on LC-MS: what the trials say vs what this community says in c/hplc · 184 points · 6 months ago
area% and mass% are not the same and this whole post conflates them
Adding to this: LC-MS is doing more work than the comment implies.
comment on help me understand exit scam, I have read the wiki twice in c/scamalerts · 1 points · 6 months ago
The Medutest results I got back showed 93.7% but ERP claimed 97.4%. Same vial, two services. I posted the receipts.
comment on three years of chargeback threads, summarised so you do not have to read them in c/cryptopay · 36 points · 7 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on [Question] New Zealand — has anyone got a straight answer on USDC in c/cryptopay · 63 points · 7 months ago
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
comment on [PSA] food noise is not what most of this community thinks it is in c/semaglutide · 18 points · 7 months ago
the 2.4mg dose is not the target, it is just what the pen goes up to
comment on reading Canada threads from 2024 and half of it aged badly in c/glp1canada · 181 points · 8 months ago
comment on weekly dosing is the most under-discussed thing in c/labresults in c/semaglutide · 29 points · 8 months ago
Sceptical.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on [Results] 12 weeks, 35kg, and special authorization was the hard part in c/glp1canada · -15 points · 8 months ago
the the Netherlands answer is not the the Netherlands answer
comment on fake COA: what the trials say vs what this community says in c/scamalerts · 29 points · 8 months ago
fake COAs always have the same tell: perfect results, zero variance
comment on my eGFR moved and I cannot work out whether HPLC is why in c/hplc · 42 points · 9 months ago
the gradient is doing the separation work, not the column alone
comment on small win: titration stopped being a problem at week 41 in c/semaglutide · 1 points · 10 months ago
titration speed is titration plus side effects, period
comment on genuine question about gradient that I am slightly embarrassed to ask in c/hplc · 43 points · 10 months ago
Not convinced. The evidence does not support that reading.